Clinical Trial Update: Onset Motor Complications Using REQUIP CR (Ropinirole Controlled-release) As Add-on Therapy To L-dopa In Parkinson's [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating ropinirole CR as add-on therapy to levodopa in Parkinson's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Requip CR (ropinirole (extended-release))
• levodopa (levodopa)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Parkinson's Disease, Parkinson Disease | Phase 3 | Status: COMPLETED